Republic of Korea vs Luxembourg: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Republic of Korea
97.0%
in 2024
Luxembourg
97.0%
in 2024
Republic of Korea rank
11th
Luxembourg rank
11th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Republic of Korea
- Luxembourg
How they compare
Republic of Korea currently reports 97.0% against 97.0% in Luxembourg, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Republic of Korea ahead.
Republic of Korea ranks 11th and Luxembourg ranks 11th of 146 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Korea | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.4% | 95.4% | 2.0% | Republic of Korea |
| 2020s | 97.0% | 96.6% | 0.4% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Republic of Korea or Luxembourg?
- Republic of Korea, at 97.0% against 97.0% in Luxembourg as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Republic of Korea and Luxembourg?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Luxembourg?
- 10 years are reported by both, from 2015 to 2024.
- How do Republic of Korea and Luxembourg rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Republic of Korea ranks 11th and Luxembourg ranks 11th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.